1. United States
2. Ore.
3. Letter

I'm writing to urge you to support 2027 legislation requiring insurance companies to cover biomarker testing.. Nearly half of U.S. states already require this. Oregon shouldn't be playing catch-up on something this basic. Biomarker tests are FDA-approved. They are not experimental, not optional extras. They're the difference between months of guesswork and an answer in days. For cancer patients, they're the key to treatment that's actually targeted to their disease instead of one-size-fits-all interventions that may not even work. This is a fiscally smart ask, too. Paying for ineffective treatments isn't just bad medicine; it's wasted money. Every round of chemo that doesn't work, every drug trial-and-error cycle, every misdiagnosis-driven specialist visit costs the system real dollars. Biomarker testing gets patients to the right treatment faster, which means fewer wasted dollars on treatments that were never going to work in the first place. This isn't a partisan ask. It's common sense: give doctors and patients real diagnostic tools instead of forcing them to gamble. Two dozen-plus states have already figured this out. Oregon should too. Please commit to supporting biomarker testing coverage legislation in 2027. Thank you.